Results 41 to 50 of about 63,906 (257)
Structure and Evolution of Acinetobacter baumannii Plasmids [PDF]
Frontiers in Microbiology, 2020 Acinetobacter baumannii is an emergent bacterial pathogen that provokes many types of infections in hospitals around the world. The genome of this organism consists of a chromosome and plasmids. These plasmids vary over a wide size range and many of them have been linked to the acquisition of antibiotic-resistance genes.
Abraham D. Salgado-Camargo +9 more
openaire +3 more sources
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Advanced Materials, EarlyView.Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source
Advanced Science, EarlyView.High‐throughput single‐cell analysis of resuscitating bacteria reveals a starvation‐history‐dependent transiently tolerant subpopulation that survives β$\beta$‐lactam exposure by temporarily reducing growth. Distinct from classical persisters, these actively growing yet dynamically modulated cells dominate survival across clinically relevant antibiotic
Kieran Abbott +5 more
wiley +1 more source
Core and variable components in prokaryotic genomes [PDF]
, 2011 Acinetobacter baumannii and Stenotrophomonas maltophilia are opportunistic pathogens responsable for several hospital-acquired infections. We performed Extensive comparative analyses were performed in silico to elucidate the cromosomal organization of ...
Rocco, Francesco
core
Revisiting Drug Resistance Mechanisms Of A Notorious Nosocomial Pathogen: Acinetobacter Baumannii [PDF]
, 2022 Mini review on mechanisms and strategies expressed by A. baumannii to resist biological compounds with antagonistic activity on their growth. Acinetobacter baumannii (A.
Phofa, Dikwata Thabiso +3 more
core +2 more sources
Treatment of Acinetobacter baumannii
, 2023 Acinetobacter baumannii is a Priority 1 pathogen under the WHO list for research and discovery of new antibiotics. The epidemiology of the pathogen suggests its relevance as an important “healthcare-associated” pathogen—with the most common clinical syndrome being ventilator-associated pneumonia.
Anup R. Warrier, Sneha Radha
openaire +1 more source
Antimicrobial Resistance and Infection Control, 2018 Background Acinetobacter baumannii nosocomial ventriculitis/meningitis, especially those due to drug-resistant strains, has substantially increased over recent years.
Wei Guo +4 more
doaj +1 more source
Polychip‐A High‐Throughput Droplet Microfluidics Platform for Interrogating Microbial Interactions
Advanced Science, EarlyView.Polychip, a fully integrated droplet microfluidics platform, enables high‐throughput, single‐cell resolution screening of polymicrobial interactions. By seamlessly combining six automated microfluidics operations on a single chip, the system accelerates antimicrobial discovery by 11 to 14 times compared to traditional robotic methods.
Jeong Jae Han +11 more
wiley +1 more source
Investigation of the prevalence and role of mobile genetic elements associated with an aminoglycoside resistance gene, aacC2a, in Acinetobacter baumannii [PDF]
, 2009 Includes abstract. Includes bibliographical references (leaves 115-141)
Jongwe, Tsungai Ivai
core
Clinical Characteristics of Tertiary Hospital Patients from Whom Acinetobacter calcoaceticus-Acinetobacter baumannii Complex Strains were Isolated [PDF]
, 2012 Objective Acinetobacter baumannii is a worldwide nosocomial pathogen that has become increasingly common over the past few decades, and strains of multidrug-resistant A. baumannii have been increasing.
Yamada, Koichi +12 more
core +1 more source